We are live on ! Find out more
IVAV

Index Venture Associates V Portfolio holdings

AUM $1.46M
1-Year Est. Return 88.05%
This Fund
S&P 500
This Quarter Est. Return
-22.69%
1 Year Est. Return
-88.05%
3 Year Est. Return
-61.2%
5 Year Est. Return
-86%
10 Year Est. Return
–
AUM
$595M
AUM Growth
-$176M
Cap. Flow
-$863K
Cap. Flow %
-0.15%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NERV icon
Minerva Neurosciences
NERV
+$863K

Sector Composition

Rank Sector Weight
1 Industrials 99.15%
2 Healthcare 0.72%
3 Technology 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTCH
1
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$590M 99.15%
28,359,930
– –
NERV icon
2
Minerva Neurosciences
NERV
$188M
$4.27M 0.72%
94,742
-17,252
-15% -$863K
DBX icon
3
Dropbox
DBX
$6.81B
$810K 0.14%
32,321
– –

Similar funds

VM
Value Monitoring Menlo Park, California $1.5M AUM 13.21% 1-Year Est. Return
CL
CRV LLC Palo Alto, California $1.56M AUM 87.36% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
HCIG
H Capital II GP Grand Cayman, Cayman Islands $1.83M AUM
GAM
GVO Asset Management Zug, Switzerland $1.07M AUM 24.36% 1-Year Est. Return
MC
Manteio Capital Jersey City, New Jersey $1.05M AUM
NC
Noked Capital Tel Aviv, Israel $946K AUM 17.1% 1-Year Est. Return
NP
Nimble Partners San Francisco, California $556K AUM 61.7% 1-Year Est. Return

Index Venture Associates V's Q2 2019 Portfolio in Review

As of Q2 2019, Index Venture Associates V held 3 positions worth $595M, down 23% from $771M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 0%. Index Venture Associates V opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 99% of assets, up from 99% a quarter earlier, followed by Healthcare and Technology.

  • Index Venture Associates V's biggest Q2 2019 reduction was Minerva Neurosciences, cutting an estimated $863K.
  • Index Venture Associates V's ten largest holdings make up 100% of its $595M portfolio in Q2 2019.
  • Index Venture Associates V opened 0 new positions and closed 0 in Q2 2019.
  • Index Venture Associates V's portfolio value fell 23% quarter-over-quarter to $595M.

Based on Index Venture Associates V's 13F filing for Q2 2019, filed 14 Aug 2019.